Bioimplon GmbH focusses on the development and manufacturing of unique, natural bioregenerative products in the field of regenerative medicine. Their extensive product range covers bone and tissue regeneration, tissue engineering and wound healing for dental, spinal, orthopaedic and plastic surgery applications. They are used by oral and maxillofacial surgeons, periodontists and dental implantologists, as well as by orthopaedic, spinal, general and plastic surgeons. Bioimplon relies on its highly qualified and specialised staff in the field of bioregenerative medicine, investing heavily in the development of research and technology. Bioimplon has reached 46 countries around the world and continues to expand and grow within the industry.
Biomatlante is a world leader in bone grafting technology, specialising in producing synthetic biomaterials for bone regeneration, selling its products in over 50 countries around the world. Their products are used in orthopaedics and trauma surgery, ENT, stomatology and dental surgery. Owning patents and licence rights in biomaterials and new technologies, Biomalante’s global process integrates a strategy of strong innovation, setting higher reactivity facing the evolution and the demands of the market. Partnered with CNRS (French National Center For Scientific Research), INSERM (National Institute of Health and Medical Research) and other national and international universities, they can improve competence in innovation, new surgical technologies and technological transfers of new biomaterials.
Medipac was established in December 1987, with headquarters in the industrial area of Stavrohori, prefecture of Kilkis. The exclusive aim of the company is the fabrication of surgical sutures. With their own unique production unit in Greece, Medipac has also secured exclusive distribution contracts with many important public hospitals in Greece since 1989. From the beginning, Medipac’s principle aim was to strive to produce high quality products, consequently resulting in certification in accordance with the requirements of the Quality Inspection System ISO – 9001, in compliance with the Common Harmonised Technical Standards by European Pharmacopeia (CE mark – directive 93/42/EC). Today, Medipac produces a wide and integrated line of surgical sutures and possesses a high percentage of the local market.
Novadento is a specialist in the development and distribution of biomaterials for regenerative dental solutions. Their main objective is to ensure the success of practitioners by offering superior product solutions which provide better and simpler treatment, based on functional and exceptional advantages. Novadento have developed innovative and effective biomaterials for dental bone and tissue regeneration. Constant contact with worldwide reputable researchers and practitioners contributed to their goals of realising tailor-made product concepts into valid product solutions for clinical practise. All of which is based on the experience of a highly qualified team and unique technology platforms.